Operating Lease, Liability in USD of Sonnet BioTherapeutics Holdings, Inc. from Q1 2019 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Sonnet BioTherapeutics Holdings, Inc. quarterly Operating Lease, Liability history and change rate from Q1 2019 to Q3 2024.
Sonnet BioTherapeutics Holdings, Inc. Operating Lease, Liability for the quarter ending 30 Sep 2024 was $130,864, a 35.8% decline year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Change (%)

Sonnet BioTherapeutics Holdings, Inc. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2024	$130,864	-$73,047	-36%	30 Sep 2024	10-K	17 Dec 2024	2024	FY
Q3 2023	$203,911	-$51,329	-20%	30 Sep 2023	10-K	14 Dec 2023	2023	FY
Q3 2022	$255,240	+$130,108	+104%	30 Sep 2022	10-K	15 Dec 2022	2022	FY
Q2 2022	$271,934	+$125,231	+85%	30 Jun 2022	10-Q	15 Aug 2022	2022	Q3
Q3 2021	$125,132	-$82,060	-40%	30 Sep 2021	10-K	17 Dec 2021	2021	FY
Q2 2021	$146,703	-$79,157	-35%	30 Jun 2021	10-Q	16 Aug 2021	2021	Q3
Q1 2021	$167,686	-$17,080,133	-99%	31 Mar 2021	10-Q	17 May 2021	2021	Q2
Q4 2020	$187,951	-$17,493,712	-99%	31 Dec 2020	10-Q	16 Feb 2021	2021	Q1
Q3 2020	$207,192	-$18,943,192	-99%	30 Sep 2020	10-K	17 Dec 2020	2020	FY
Q2 2020	$225,860	-$20,169,367	-99%	30 Jun 2020	10-Q	14 Aug 2020	2020	Q3
Q1 2020	$17,247,819	-$3,731,155	-18%	31 Mar 2020	10-Q	18 May 2020	2020	Q1
Q4 2019	$17,681,663			31 Dec 2019	10-Q	18 May 2020	2020	Q1
Q3 2019	$19,150,384			30 Sep 2019	10-Q	14 Nov 2019	2019	Q3
Q2 2019	$20,395,227			30 Jun 2019	10-Q	14 Aug 2019	2019	Q2
Q1 2019	$20,978,974			31 Mar 2019	10-Q	15 May 2019	2019	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.